Abstract:
India’s vast population has positioned the country as a major hub for clinical research, drawing considerable global pharmaceutical interest. While the Indian Council of Medical Research guidelines and the New Drugs and Clinical Trials Rules 2019, provide a robust national framework for ethical conduct, their implementation across medical institutions remains inconsistent. This variability is reflected in the functioning of Institutional Ethics Committees (IECs) across various medical institutions in India especially during the period of 2018 2025. In-order to address the lackadaisical performance of the institute ethics Committees, a common ethical governance framework should be created, which could lead to transparency, accountability, and expertise with the use of artificial intelligence and machine learning. However, full utilization of IECs should be en abled, with the goal being to make ethical practice uniform across emerging and already established medical institutions in India, and setting a standard in this respect globally.